These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31647875)

  • 21. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.
    Zhan P; Wang L; Liu H; Chen X; Li X; Jiang X; Zhang Q; Liu X; Pannecouque C; Naesens L; De Clercq E; Liu A; Du G
    Arch Pharm Res; 2012 Jun; 35(6):975-86. PubMed ID: 22870806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening.
    Liu M; Lo CY; Wang G; Chow HF; Ngo JC; Wan DC; Poon LL; Shaw PC
    Antiviral Res; 2017 Aug; 144():186-195. PubMed ID: 28629986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Multitarget-Directed Ligands Against Influenza A Virus From Compound Yizhihao Through a Predictive System for Compound-Protein Interactions.
    Xu L; Jiang W; Jia H; Zheng L; Xing J; Liu A; Du G
    Front Cell Infect Microbiol; 2020; 10():16. PubMed ID: 32117796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected mice.
    Pizzorno A; Abed Y; Plante PL; Carbonneau J; Baz M; Hamelin MÈ; Corbeil J; Boivin G
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6398-405. PubMed ID: 25114143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a small-molecule inhibitor of influenza virus via disrupting the subunits interaction of the viral polymerase.
    Yuan S; Chu H; Zhao H; Zhang K; Singh K; Chow BK; Kao RY; Zhou J; Zheng BJ
    Antiviral Res; 2016 Jan; 125():34-42. PubMed ID: 26593979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-benzyl 4,4-disubstituted piperidines as a potent class of influenza H1N1 virus inhibitors showing a novel mechanism of hemagglutinin fusion peptide interaction.
    de Castro S; Ginex T; Vanderlinden E; Laporte M; Stevaert A; Cumella J; Gago F; Camarasa MJ; Luque FJ; Naesens L; Velazquez S
    Eur J Med Chem; 2020 May; 194():112223. PubMed ID: 32220685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral resistance due to deletion in the neuraminidase gene and defective interfering-like viral polymerase basic 2 RNA of influenza A virus subtype H3N2.
    Trebbien R; Christiansen CB; Fischer TK
    J Clin Virol; 2018 May; 102():1-6. PubMed ID: 29448067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Novel Influenza Polymerase PB2 Inhibitors Using a Cascade Docking Virtual Screening Approach.
    Zhao L; Che J; Zhang Q; Li Y; Guo X; Chen L; Li H; Cao R; Li X
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of 1,2,3-triazolyl nucleoside analogs as potential anti-influenza A (H3N2 subtype) virus agents.
    Elayadi H; Smietana M; Vasseur JJ; Balzarini J; Lazrek HB
    Arch Pharm (Weinheim); 2014 Feb; 347(2):134-41. PubMed ID: 24272912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses.
    Fu L; Bi Y; Wu Y; Zhang S; Qi J; Li Y; Lu X; Zhang Z; Lv X; Yan J; Gao GF; Li X
    J Med Chem; 2016 Jul; 59(13):6303-12. PubMed ID: 27341624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus.
    Yamayoshi S; Watanabe M; Goto H; Kawaoka Y
    J Virol; 2016 Jan; 90(1):444-56. PubMed ID: 26491155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring.
    Little K; Leang SK; Butler J; Baas C; Harrower B; Mosse J; Barr IG; Hurt AC
    Euro Surveill; 2015; 20(45):. PubMed ID: 26608955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
    Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
    Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
    Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of a new class of antiviral compounds: camphor imine derivatives.
    Sokolova AS; Yarovaya OI; Shernyukov AV; Gatilov YV; Razumova YV; Zarubaev VV; Tretiak TS; Pokrovsky AG; Kiselev OI; Salakhutdinov NF
    Eur J Med Chem; 2015 Nov; 105():263-73. PubMed ID: 26498572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth.
    Li C; Xu LJ; Lian WW; Pang XC; Jia H; Liu AL; Du GH
    Acta Pharmacol Sin; 2018 Dec; 39(12):1913-1922. PubMed ID: 29802302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. synthesis and preliminary biologic evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhibitors.
    Li Z; Zhan P; Naesens L; Vanderlinden E; Liu A; Du G; De Clercq E; Liu X
    Chem Biol Drug Des; 2012 Jun; 79(6):1018-24. PubMed ID: 22284752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection.
    Enkhtaivan G; Muthuraman P; Kim DH
    J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.